Participated · Equity · Apr 2026

Founded in 2020 and based in Épinay-sous-Sénart (Essonne), Cosmyx develops and manufactures 3D printers and micro-usines 3D for industrial-scale additive manufacturing. The company positions itself to help industrial clients transition from prototyping to mass production and has been active in the defense sector. Cosmyx currently employs around fifteen people and plans to recruit additional staff following its recent fundraising. With the new capital, it aims to expand its commercial pipeline and pursue opportunities in medical, aeronautics, and nuclear markets. Financial details beyond the recent €1.3 million raise were not disclosed in the article.

Participated · Equity · Feb 2026

Skydrone Robotics is a La Rochelle–based drone manufacturer that has evolved over the past decade from a start-up into a small industrial SME focused on both civil and military applications. Its aircraft are tailored for logistics missions such as transporting supplies for armed forces and performing inspection work on electrical power lines. The company currently employs about 20 people—three-quarters of whom are engineers—and is hiring 10 additional staff to support expansion. Fresh capital will finance a new 2,000 m² plant capable of assembling several hundred drones per year, marking a shift from prototyping to scaled production. Management’s stated ambition is to become a leading player in the European civil-military drone market. Besides ramping manufacturing, funds will also bolster R&D and operational capacity to meet growing demand.

Participated · Equity · Oct 2025

EYST Technology offers a SaaS solution that lets insurers issue instantly funded virtual bank cards to pay claims, removing upfront payments by policyholders and replacing delayed reimbursements with immediate access to funds. The platform integrates into insurers' mobile and web channels and combines payments, risk management, and data capabilities to improve speed, transparency, and user experience. EYST's model focuses on instant claims payout via virtual cards to streamline the claims process. The company was founded in 2022 by Marwen Amamou in Tunisia. Following its recent undisclosed funding from 216 Capital, EYST plans to accelerate product development and expand into new international markets.

Led · Equity · Oct 2025

EVerZom is a biotechnology company building a proprietary GMP-compliant bioproduction platform to generate therapeutic exosomes from mesenchymal stem cells. Its approach couples exosomes with biomaterials to improve delivery and efficacy across multiple indications. The lead candidate, EVerGel, targets Crohn’s complex perianal fistulas and is scheduled to enter the clinic in 2026, while Eviv is in pre-clinical development for acute-on-chronic liver failure (ACLF). Additional exploratory programs span ophthalmology, broader regenerative medicine applications, and extra-pharma opportunities such as cosmetics and veterinary health. Proceeds from the latest round will finance the first clinical trial of EVerGel, extend the platform into hepatology and dermatology, and further scale industrial manufacturing capabilities. No revenue or user metrics have been disclosed to date.

Participated · Equity · Sep 2025

Founded in 2023, France-based Byome Labs is a deep-tech company that analyzes skin, scalp, oral, and vaginal microbiomes to match consumers with the most suitable cosmetic products. Its flagship system, Byome Derma, can read a customer’s skin microbiome in-store without invasive hardware and instantly suggest optimal products, positioning the firm as an enabler of personalized retail experiences for major cosmetics brands. The company has compiled a proprietary database of more than 5,000 microbiome profiles and built its own AI to interpret this data. Industry players such as Clarins and Shiseido are already in advanced talks to deploy the kit once production begins. Byome plans to start industrial manufacturing of Byome Derma kits by the end of 2025, expand its R&D and commercial teams, and begin international rollout across Europe, the United States, and Asia in 2026. The startup is additionally backed by ecosystem supporters including Bpifrance (Deeptech), French Tech, Cosmetic Valley, École Polytechnique, Dev’Up Centre Val de Loire, and Village by CA. No revenue figures were disclosed in the article.